Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation

Background: Sodium-glucose cotransporter 2 (SGLT2) plays a critical role in renal tubular glucose reabsorption in diabetic kidney disease (DKD). This study aimed to simulate the in vitro digestion process to obtain enzymatic hydrolysates of leeches, establish a peptide profile library of leech-derived peptides, and specifically identify potential SGLT2-interacting peptide candidates originating from leeches. Methods: Response surface methodology was employed to optimize the simulated in vitro gastrointestinal digestion process of leech proteins. A leech-derived peptide library was constructed via nano-flow liquid chromatography tandem mass spectrometry. Multi-level screening of leech peptides was completed through bioactivity scoring, absorption and toxicity prediction. Subsequently, Boltz-2 was used for virtual screening against human SGLT2 (PDB: 7VSI), followed by all-atom interaction and binding-affinity analyses. Finally, we synthesized the candidate peptides and performed experimental validation in the HK-2 cell model using cellular thermal shift assay, Western blot, and flow cytometry analysis. Results: After optimized enzymatic digestion, a total of 8816 leech-derived peptide sequences were identified, and 14 high-confidence candidate peptides were obtained by screening. Among them, PVIFPVPR, ANALPHFP, and PFIPPNKL achieved ipTM scores greater than 0.8. PVIFPVPR binds to the TM4 region of SGLT2 mainly through hydrophobic interactions and hydrogen bonds. Furthermore, this peptide exhibits excellent capacity to improve the thermal stability of SGLT2. It also down-regulated the expression of SGLT2 and N-cadherin, restored E-cadherin levels, and reduced excessive glucose uptake in HK-2 cells. Conclusions: The leech-derived peptide PVIFPVPR is a potential SGLT2-interacting candidate and was associated with attenuated fibrosis and aberrant glucose uptake in HK-2 cells. This novel leech derived peptide represents a candidate peptide with potential relevance to SGLT2 associated pathways for further preclinical investigation of DKD-related tubular injury.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-19
DOI
https://doi.org/10.3390/ph19111846
Primary Topic
Protein Hydrolysis and Bioactive Peptides
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation

Xiangyan Li, Hang Su, Zuguo Liang, ZiChen Tian et al.
Pharmaceuticals
Protein Hydrolysis and Bioactive Peptides
article

Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation

Xiangyan Li, Hang Su, Zuguo Liang, ZiChen Tian, Chuanwang Sun
article en

Abstract

Background: Sodium-glucose cotransporter 2 (SGLT2) plays a critical role in renal tubular glucose reabsorption in diabetic kidney disease (DKD). This study aimed to simulate the in vitro digestion process to obtain enzymatic hydrolysates of leeches, establish a peptide profile library of leech-derived peptides, and specifically identify potential SGLT2-interacting peptide candidates originating from leeches. Methods: Response surface methodology was employed to optimize the simulated in vitro gastrointestinal digestion process of leech proteins. A leech-derived peptide library was constructed via nano-flow liquid chromatography tandem mass spectrometry. Multi-level screening of leech peptides was completed through bioactivity scoring, absorption and toxicity prediction. Subsequently, Boltz-2 was used for virtual screening against human SGLT2 (PDB: 7VSI), followed by all-atom interaction and binding-affinity analyses. Finally, we synthesized the candidate peptides and performed experimental validation in the HK-2 cell model using cellular thermal shift assay, Western blot, and flow cytometry analysis. Results: After optimized enzymatic digestion, a total of 8816 leech-derived peptide sequences were identified, and 14 high-confidence candidate peptides were obtained by screening. Among them, PVIFPVPR, ANALPHFP, and PFIPPNKL achieved ipTM scores greater than 0.8. PVIFPVPR binds to the TM4 region of SGLT2 mainly through hydrophobic interactions and hydrogen bonds. Furthermore, this peptide exhibits excellent capacity to improve the thermal stability of SGLT2. It also down-regulated the expression of SGLT2 and N-cadherin, restored E-cadherin levels, and reduced excessive glucose uptake in HK-2 cells. Conclusions: The leech-derived peptide PVIFPVPR is a potential SGLT2-interacting candidate and was associated with attenuated fibrosis and aberrant glucose uptake in HK-2 cells. This novel leech derived peptide represents a candidate peptide with potential relevance to SGLT2 associated pathways for further preclinical investigation of DKD-related tubular injury.

PharmaceuticalsVol. 19(11)
Changchun University of Chinese Medicine (CN)
Protein Hydrolysis and Bioactive Peptides
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon